ASLAN Pharmaceuticals Limited [ASLN] moved up 7.91: Why It’s Important

ASLAN Pharmaceuticals Limited [NASDAQ: ASLN] jumped around 0.25 points on Friday, while shares priced at $3.41 at the close of the session, up 7.91%. The company report on May 25, 2021 that ASLAN Pharmaceuticals to Participate In Fireside Chat at Jefferies Virtual Healthcare Conference.

>> 7 Top Picks for the Post-Pandemic Economy <<

ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced Dr Carl Firth, Chief Executive Officer of the company, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Tuesday, 1 June, 2021 at 11:30am ET. The conference will be held from 1-4 June 2021.

A live webcast of the chat will be available using this link: https://wsw.com/webcast/jeff174/asln/1851714 and in the Investor Relations section of ASLAN’s website at www.aslanpharma.com, with a replay available shortly after the event.

ASLAN Pharmaceuticals Limited stock is now 86.34% up from its year-to-date (YTD) trading value. ASLN Stock saw the intraday high of $3.81 and lowest of $3.30 per share. The company’s 52-week high price is 6.75, which means current price is +89.44% above from all time high which was touched on 03/01/21.

Compared to the average trading volume of 454.48K shares, ASLN reached a trading volume of 22883139 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about ASLAN Pharmaceuticals Limited [ASLN]?

Jefferies have made an estimate for ASLAN Pharmaceuticals Limited shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 09, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $12 to $8.50. The new note on the price target was released on January 14, 2019, representing the official price target for ASLAN Pharmaceuticals Limited stock.

The Average True Range (ATR) for ASLAN Pharmaceuticals Limited is set at 0.26

How has ASLN stock performed recently?

ASLAN Pharmaceuticals Limited [ASLN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.10. With this latest performance, ASLN shares gained by 9.65% in over the last four-week period, additionally plugging by 69.65% over the last 6 months – not to mention a rise of 76.68% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASLN stock in for the last two-week period is set at 55.77, with the RSI for the last a single of trading hit 57.11, and the three-weeks RSI is set at 54.73 for ASLAN Pharmaceuticals Limited [ASLN]. The present Moving Average for the last 50 days of trading for this stock 3.11, while it was recorded at 3.26 for the last single week of trading, and 2.69 for the last 200 days.

ASLAN Pharmaceuticals Limited [ASLN]: Deeper insight into the fundamentals

Return on Total Capital for ASLN is now -124.52, given the latest momentum, and Return on Invested Capital for the company is -151.08. Additionally, ASLN Total Debt to Total Capital is recorded at 224.37, with Total Debt to Total Assets ending up at 117.26.

Reflecting on the efficiency of the workforce at the company, ASLAN Pharmaceuticals Limited [ASLN] managed to generate an average of -$899,883 per employee.ASLAN Pharmaceuticals Limited’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 1.50.

Insider trade positions for ASLAN Pharmaceuticals Limited [ASLN]

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in ASLAN Pharmaceuticals Limited stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 34 institutional holders increased their position in ASLAN Pharmaceuticals Limited [NASDAQ:ASLN] by around 22,299,082 shares. Additionally, 5 investors decreased positions by around 966,792 shares, while 2 investors held positions by with 4,357,225 shares. The mentioned changes placed institutional holdings at 27,623,099 shares, according to the latest SEC report filing. ASLN stock had 29 new institutional investments in for a total of 21,573,859 shares, while 0 institutional investors sold positions of 0 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam